查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586123

心臟再同步治疗设备市场：按产品、最终用户划分 - 全球预测 2025-2030 年

Cardiac Resynchronization Therapy Devices Market by Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals & Cardiac Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心臟再同步治疗设备市场价值为49.8亿美元，预计2024年将达53.6亿美元，复合年增长率为7.70%，到2030年将达到83.8亿美元。

心臟再同步治疗（CRT）设备透过电脉衝提高心臟的效率和收缩协调性，在心臟衰竭的治疗中发挥至关重要的作用。心臟相关疾病（尤其是心臟衰竭）的日益普及推动了对 CRT 的需求，而世界人口老化、久坐生活方式的增加以及肥胖率的上升往往加剧了心臟衰竭。这些设备主要用于治疗传统治疗方法不足以治疗严重心臟衰竭的患者。无线 CRT 和多点起搏等技术进步正在将最终用途扩大到医院、诊所和心臟护理中心。

主要市场统计
基准年[2023] 49.8亿美元
预测年份 [2024] 53.6亿美元
预测年份 [2030] 83.8亿美元
复合年增长率（%） 7.70%

根据市场洞察，一个关键的成长要素是人们对心血管疾病的认识不断提高以及由此引起的对预防性医疗保健的关注。技术创新和有利的报销政策也推动了 CRT 设备的采用。然而，高设备成本、潜在副作用和严格的监管核准流程等限制可能会对市场成长带来挑战。此外，缺乏熟练的专业人员来操作这些设备限制了它们的采用，特别是在发展中地区。潜在的机会在于透过策略联盟扩大市场覆盖范围，并利用人工智慧和巨量资料分析的兴起来改善设备功能和患者治疗结果。

专注于降低设备成本、延长电池寿命和提高患者依从性的研究投资可以刺激创新。此外，开拓的微创植入技术可以扩大市场接受度。随着以患者为中心的护理成为优先事项，用于远端监控和个人化治疗的智慧技术的整合仍然至关重要。由于技术创新和医疗保健支出的增加，市场竞争激烈且快速发展。解决可及性和病患教育的差距可以获得显着的红利。透过专注于技术创新、策略伙伴关係以及企业发展到新兴市场，在这一领域运营的公司将在克服市场挑战的同时看到巨大的成长机会。

市场动态：快速发展的心臟再同步治疗设备市场的关键市场洞察

心臟再同步治疗设备市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 心血管疾病和目标疾病的发生率增加
    • 全球加护病房数量不断增加
    • 已开发国家和新兴国家医疗保健支出快速成长
  • 市场限制因素
    • CRT设备高成本
  • 市场机会
    • 心臟再同步治疗设备中先进技术的集成
    • 新型和创新的 CRT 设备简介
  • 市场挑战
    • 缺乏操作心臟再同步治疗装置的熟练人员

波特五力：引领心臟再同步治疗设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心臟再同步治疗设备市场的外部影响

外部宏观环境因素在塑造心臟再同步治疗设备市场的性能动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心臟再同步治疗设备市场的竞争格局

心臟再同步治疗设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心臟再同步治疗设备市场供应商的绩效评估

FPNV定位矩阵是评估心臟再同步治疗设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心臟再同步治疗设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对心臟再同步治疗设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病和目标疾病的发生率增加
      • 全球加护病房数量不断增加
      • 已开发国家和新兴国家的医疗费用快速增加
    • 抑制因素
      • CRT设备高成本
    • 机会
      • 心臟再同步治疗设备中先进技术的集成
      • 新型创新 CRT 设备简介
    • 任务
      • 缺乏操作心臟再同步治疗装置的熟练人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心臟再同步治疗设备市场：依产品

  • 心臟再同步治疗心臟去颤器
  • 心臟再同步治疗心律调节器

第七章心臟再同步治疗设备市场：依最终使用者分类

  • 门诊手术中心
  • 医院和心臟中心

第八章美洲心臟再同步治疗设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太心臟再同步治疗设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲心臟再同步治疗设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corporation
  • EBR Systems, Inc.
  • General Electric Company
  • Japan Lifeline Co., Ltd.
  • Koninklijke Philips NV
  • Livanova PLC
  • MEDICO SRL
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation
  • Osypka Medical GmbH
  • Siemens AG
  • St. Jude Medical, LLC
Product Code: MRR-433AB1DC2896

The Cardiac Resynchronization Therapy Devices Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.36 billion in 2024, and is projected to grow at a CAGR of 7.70%, to USD 8.38 billion by 2030.

Cardiac Resynchronization Therapy (CRT) devices play a pivotal role in managing heart failure by improving the heart's efficiency and coordination of its contractions through electrical impulses. The necessity for CRT devices stems from the growing prevalence of heart-related disorders, especially heart failure, which is often exacerbated by an aging global population, increasing sedentary lifestyles, and rising obesity rates. These devices are primarily used to treat individuals suffering from severe heart dysfunction when conventional therapies prove insufficient. The end-use scope extends to hospitals, clinics, and specialized heart care centers, driven by technological advancements like wireless CRTs and multi-point pacing.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.36 billion
Forecast Year [2030] USD 8.38 billion
CAGR (%) 7.70%

Market insights reveal that significant growth factors are the rising awareness of cardiovascular diseases and the subsequent focus on preventive healthcare. Technological innovations and favorable reimbursement policies also boost the adoption of CRT devices. However, limitations like high device costs, potential side effects, and the stringent regulatory approval process can pose challenges to market growth. Additionally, a lack of skilled professionals to operate these devices limits their widespread adoption, especially in developing regions. Potential opportunities lie in expanding market reach through strategic collaborations and leveraging emerging artificial intelligence and big data analytics to refine device functionalities and patient outcomes.

Investment in research focusing on reducing device costs, enhancing battery life, and improving patient compliance can stimulate innovation. Developing minimally invasive implantation techniques can also widen market acceptance. With patient-centered care becoming a priority, integrating smart technologies for remote monitoring and personalized therapy remains crucial. The nature of the market is competitive and rapidly evolving, driven by technological breakthroughs and increasing healthcare expenditure. Addressing the gaps in accessibility and patient education could yield substantial dividends. For businesses operating in this domain, a focus on technological innovation, strategic partnerships, and expanding in emerging markets could unlock substantial growth opportunities while overcoming prevailing market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Resynchronization Therapy Devices Market

The Cardiac Resynchronization Therapy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of cardiovascular and target diseases
    • Growing number of intensive care units globally
    • Surge in healthcare expenditure across developed and developing countries
  • Market Restraints
    • High cost of CRT devices
  • Market Opportunities
    • Integration of advanced technologies in cardiac resynchronization therapy devices
    • Introduction of new and innovative CRT devices
  • Market Challenges
    • Lack of skilled personnel to operate cardiac resynchronization therapy devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Resynchronization Therapy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Resynchronization Therapy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Resynchronization Therapy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Resynchronization Therapy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Resynchronization Therapy Devices Market

A detailed market share analysis in the Cardiac Resynchronization Therapy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Resynchronization Therapy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Resynchronization Therapy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Resynchronization Therapy Devices Market

A strategic analysis of the Cardiac Resynchronization Therapy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Resynchronization Therapy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, EBR Systems, Inc., General Electric Company, Japan Lifeline Co., Ltd., Koninklijke Philips N.V., Livanova PLC, MEDICO S.R.L., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Osypka Medical GmbH, Siemens AG, and St. Jude Medical, LLC.

Market Segmentation & Coverage

This research report categorizes the Cardiac Resynchronization Therapy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Resynchronization Therapy Defibrillators and Cardiac Resynchronization Therapy Pacemakers.
  • Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals & Cardiac Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cardiovascular and target diseases
      • 5.1.1.2. Growing number of intensive care units globally
      • 5.1.1.3. Surge in healthcare expenditure across developed and developing countries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRT devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies in cardiac resynchronization therapy devices
      • 5.1.3.2. Introduction of new and innovative CRT devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled personnel to operate cardiac resynchronization therapy devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Resynchronization Therapy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy Defibrillators
  • 6.3. Cardiac Resynchronization Therapy Pacemakers

7. Cardiac Resynchronization Therapy Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Hospitals & Cardiac Centers

8. Americas Cardiac Resynchronization Therapy Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Resynchronization Therapy Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Resynchronization Therapy Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Biotronik AG
  • 3. Boston Scientific Corporation
  • 4. EBR Systems, Inc.
  • 5. General Electric Company
  • 6. Japan Lifeline Co., Ltd.
  • 7. Koninklijke Philips N.V.
  • 8. Livanova PLC
  • 9. MEDICO S.R.L.
  • 10. Medtronic PLC
  • 11. Merit Medical Systems, Inc.
  • 12. Microport Scientific Corporation
  • 13. Osypka Medical GmbH
  • 14. Siemens AG
  • 15. St. Jude Medical, LLC

LIST OF FIGURES

  • FIGURE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY HOSPITALS & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023